AVD · American Vanguard Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $123.57M | - | $119.31M | $129.31M | $115.80M | - | $118.31M | $128.21M | $135.14M | - |
| Cost of Revenue | $85.15M | - | $85.10M | $88.77M | $85.61M | - | $101.01M | $90.45M | $92.72M | - |
| Gross Profit | $38.42M | - | $34.21M | $40.55M | $30.19M | - | $17.29M | $37.76M | $42.42M | - |
| R&D | $5.27M | - | $5.65M | $5.80M | $5.68M | - | $11.18M | $9.41M | $5.71M | - |
| SG&A | $27.71M | - | $26.75M | $28.76M | $26.63M | - | $29.81M | $31.05M | $30.62M | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $4.68M | - | $1.62M | $1.66M | $4.74M | - | $2.29M | $2.19M | $5.44M | - |
| Operating Income | $1.89M | - | ($6.50M) | $4.37M | ($4.31M) | - | ($28.39M) | ($9.23M) | $6.09M | - |
| Interest Expense | $5.79M | - | $4.92M | $4.45M | $3.77M | - | $4.38M | $3.92M | $3.69M | - |
| Income Tax | $124.0K | - | $422.0K | $765.0K | $387.0K | - | ($7.02M) | ($1.55M) | $1.48M | - |
| Net Income | ($4.14M) | - | ($12.36M) | ($849.0K) | ($8.46M) | - | ($25.74M) | ($11.72M) | $1.55M | - |
| EPS - Basic | ($0.14) | - | ($0.43) | ($0.03) | ($0.30) | - | ($0.91) | ($0.42) | $0.06 | - |
| EPS - Diluted | ($0.14) | - | ($0.43) | ($0.03) | ($0.30) | - | ($0.91) | ($0.42) | $0.06 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $70.91M | $12.43M | $16.80M | $14.48M | $11.80M | $12.51M | $11.88M | $17.95M | $13.71M | $11.42M |
| Accounts Receivable | $179.34M | $160.51M | $167.14M | $169.48M | $159.56M | $169.74M | $146.15M | $192.08M | $187.20M | $182.61M |
| Inventory | $175.04M | $176.03M | $199.00M | $191.50M | $184.60M | $179.29M | $246.04M | $244.94M | $228.31M | $219.55M |
| Accounts Payable | $90.67M | $87.50M | $84.20M | $96.78M | $93.92M | $69.16M | $73.56M | $93.91M | $64.64M | $68.83M |
| Current Assets | $443.55M | $370.52M | $406.47M | $399.33M | $377.85M | $378.89M | $425.11M | $477.58M | $446.94M | $432.02M |
| Total Assets | $665.24M | $596.54M | $655.01M | $651.98M | $631.59M | $636.72M | $759.46M | $807.46M | $781.63M | $767.55M |
| Current Liabilities | $190.92M | $209.45M | $230.17M | $208.74M | $213.06M | $232.35M | $225.30M | $214.93M | $195.42M | $230.50M |
| Long-term Debt | $264.38M | $174.00M | $182.25M | $189.50M | $167.50M | $147.33M | $178.75M | $211.25M | $187.02M | $138.90M |
| Total Liabilities | $475.62M | $404.14M | $434.02M | $421.16M | $404.23M | $403.61M | $431.55M | $454.23M | $410.04M | $397.54M |
| Stockholders' Equity | $189.62M | $192.40M | $220.99M | $230.82M | $227.35M | $233.11M | $327.91M | $353.23M | $371.58M | $370.01M |
| Retained Earnings | $150.85M | $155.00M | $183.21M | $195.57M | $196.42M | $204.88M | $295.31M | $321.05M | $333.61M | $332.90M |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($35.44M) | - | - | - | ($20.58M) | - | - | - | ($42.42M) | - |
| Investing Cash Flow | ($973.0K) | - | - | - | ($446.0K) | - | - | - | ($3.57M) | - |
| Financing Cash Flow | $95.01M | - | - | - | $19.80M | - | - | - | $47.70M | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 31.1% | - | 28.7% | 31.4% | 26.1% | - | 14.6% | 29.5% | 31.4% | - |
| Operating margin | 1.5% | - | -5.5% | 3.4% | -3.7% | - | -24.0% | -7.2% | 4.5% | - |
| EBITDA margin | 5.3% | - | -4.1% | 4.7% | 0.4% | - | -22.1% | -5.5% | 8.5% | - |
| Net margin | -3.4% | - | -10.4% | -0.7% | -7.3% | - | -21.8% | -9.1% | 1.1% | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | 4.3% | - | 4.7% | 4.5% | 4.9% | - | 9.4% | 7.3% | 4.2% | - |
| SG&A / Revenue | 22.4% | - | 22.4% | 22.2% | 23.0% | - | 25.2% | 24.2% | 22.7% | - |
| Effective tax rate | - | - | - | - | - | - | - | - | 48.9% | - |
| Return on assets | -0.6% | - | -1.9% | -0.1% | -1.3% | - | -3.4% | -1.5% | 0.2% | - |
| Return on equity | -2.2% | - | -5.6% | -0.4% | -3.7% | - | -7.9% | -3.3% | 0.4% | - |
| Return on invested capital | 0.3% | - | -1.3% | 0.8% | -0.9% | - | -4.4% | -1.3% | 0.6% | - |
| Liquidity | ||||||||||
| Current ratio | 2.32 | 1.77 | 1.77 | 1.91 | 1.77 | 1.63 | 1.89 | 2.22 | 2.29 | 1.87 |
| Quick ratio | 1.41 | 0.93 | 0.90 | 1.00 | 0.91 | 0.86 | 0.79 | 1.08 | 1.12 | 0.92 |
| Cash ratio | 0.37 | 0.06 | 0.07 | 0.07 | 0.06 | 0.05 | 0.05 | 0.08 | 0.07 | 0.05 |
| Leverage | ||||||||||
| Debt / Equity | 1.39 | 0.90 | 0.82 | 0.82 | 0.74 | 0.63 | 0.55 | 0.60 | 0.50 | 0.38 |
| Debt / Assets | 0.40 | 0.29 | 0.28 | 0.29 | 0.27 | 0.23 | 0.24 | 0.26 | 0.24 | 0.18 |
| Debt / EBITDA | 40.22 | - | - | 31.45 | 385.94 | - | - | - | 16.22 | - |
| Interest coverage | 0.3x | - | -1.3x | 1.0x | -1.1x | - | -6.5x | -2.4x | 1.6x | - |
| Equity multiplier | 3.51 | 3.10 | 2.96 | 2.82 | 2.78 | 2.73 | 2.32 | 2.29 | 2.10 | 2.07 |
| Liabilities / Assets | 0.71 | 0.68 | 0.66 | 0.65 | 0.64 | 0.63 | 0.57 | 0.56 | 0.52 | 0.52 |
| Efficiency | ||||||||||
| Asset turnover | 0.19 | - | 0.18 | 0.20 | 0.18 | - | 0.16 | 0.16 | 0.17 | - |
| Inventory turnover | 0.49 | - | 0.43 | 0.46 | 0.46 | - | 0.41 | 0.37 | 0.41 | - |
| Days sales outstanding | 530d | - | 511d | 478d | 503d | - | 451d | 547d | 506d | - |
| Days inventory outstanding | 750d | - | 854d | 787d | 787d | - | 889d | 988d | 899d | - |
| Days payable outstanding | 389d | - | 361d | 398d | 400d | - | 266d | 379d | 254d | - |
| Cash conversion cycle | 891d | - | 1004d | 868d | 890d | - | 1074d | 1156d | 1150d | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | 215.8x | - |
| P / B | 0.4x | - | 0.7x | 0.5x | 0.5x | - | 0.5x | 0.7x | 1.0x | - |
| P / S | 0.6x | - | 1.4x | 0.9x | 1.1x | - | 1.3x | 1.9x | 2.7x | - |
| EV / EBITDA | 40.3x | - | - | 47.5x | 645.4x | - | - | - | 46.6x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 6.7% | - | 0.9% | 0.9% | -14.3% | - | -20.9% | -3.4% | 8.2% | - |
| Revenue CAGR (3y) | -0.4% | - | -7.8% | -4.4% | -8.1% | - | -7.0% | -1.6% | 5.2% | - |
| Revenue CAGR (5y) | 1.2% | - | 0.3% | 4.3% | 3.8% | - | -1.1% | 2.5% | 6.3% | - |
| Gross profit growth (YoY) | 27.2% | - | 97.8% | 7.4% | -28.8% | - | -59.9% | -12.0% | 10.1% | - |
| Operating income growth (YoY) | - | - | 77.1% | - | - | - | - | - | 86.6% | - |
| Net income growth (YoY) | 51.0% | - | 52.0% | 92.8% | - | - | -7820.6% | -1013.1% | -19.1% | - |
| EPS growth (YoY) | 53.3% | - | 52.7% | 92.9% | - | - | -9000.0% | -950.0% | -14.3% | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | -15.7% | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | -14.3% | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -16.6% | -17.5% | -32.6% | -34.7% | -38.8% | -37.0% | -8.6% | -4.3% | -0.9% | 0.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Product / service
$311.68M totalUSCrop$221.39M · 71.0%
USNon Crop$90.29M · 29.0%
Geographic
$953.29M totalUS$311.68M · 32.7%
International Customers$219.09M · 23.0%
Non Us$203.43M · 21.3%
Central And South America$119.05M · 12.5%
MX$43.24M · 4.5%
Asia$28.40M · 3.0%
AU$15.72M · 1.6%
CA$8.76M · 0.9%
Europe$1.82M · 0.2%
Africa$1.36M · 0.1%
Middle East$732.0K · 0.1%
Peer comparison
Same SIC group: Agricultural Chemicals
Comparing AMERICAN VANGUARD CORP against the 5 most active filers in the same SIC group.
Dividends
$0.00/share trailing 12 months · -100.0% YoY
| Ex-date | Per share |
|---|---|
| Jun 26, 2024 | $0.0300 |
| Mar 26, 2024 | $0.0300 |
| Dec 28, 2023 | $0.0300 |
| Sep 21, 2023 | $0.0300 |
| Jun 27, 2023 | $0.0300 |
| Mar 23, 2023 | $0.0300 |
| Dec 27, 2022 | $0.0300 |
| Sep 22, 2022 | $0.0250 |
| Jun 23, 2022 | $0.0250 |
| Mar 24, 2022 | $0.0250 |
| Dec 23, 2021 | $0.0200 |
| Sep 30, 2021 | $0.0200 |
| Jun 23, 2021 | $0.0200 |
| Mar 24, 2021 | $0.0200 |
| Dec 22, 2020 | $0.0200 |
| Mar 25, 2020 | $0.0200 |
| Dec 24, 2019 | $0.0200 |
| Oct 2, 2019 | $0.0200 |
| Jun 27, 2019 | $0.0200 |
| Mar 26, 2019 | $0.0200 |
| Dec 26, 2018 | $0.0200 |
| Oct 2, 2018 | $0.0200 |
| Jun 27, 2018 | $0.0200 |
| Mar 28, 2018 | $0.0200 |